Research & Discovery
The latest research news in genetics and genomics.
New Bladder Cancer Molecular Classification Predicts Response to Common Immunotherapy
The new subtypes could help clinicians pick alternative therapies for patients unlikely to respond to Bacillus Calmette-Guérin treatment.
Theralink to Become Subsidiary of IMAC via Stock-for-Stock Reverse Merger
Theralink will become a wholly owned subsidiary of IMAC focused on proteomic testing for guiding cancer therapy and drug development.
In the PGx-ACT trial, investigators are tracking if patients unable to fully benefit from hydrocodone, tramadol, or codeine can get on the right drug with the help of genetic testing.
Bicycle Therapeutics, German Cancer Research Center Partner on Radiopharmaceutical Development
The German research center will contribute its radioligand expertise and help Bicycle advance radio-conjugate therapies to the clinic for multiple cancers.
BostonGene, Mater Research Partner on Follicular Lymphoma Biomarker Discovery
BostonGene said it will support Mater Research's efforts to develop biomarkers of advanced follicular lymphoma, a slow-growing form of non-Hodgkin lymphoma.